A detailed history of Groupama Asset Managment transactions in Genmab A/S stock. As of the latest transaction made, Groupama Asset Managment holds 10,028 shares of GMAB stock, worth $228,437. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,028
Previous 11,383 11.9%
Holding current value
$228,437
Previous $3.43 Billion 26.78%
% of portfolio
0.03%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.13 - $30.27 $34,051 - $41,015
-1,355 Reduced 11.9%
10,028 $2.51 Billion
Q1 2024

May 14, 2024

BUY
$26.43 - $32.77 $300,852 - $373,020
11,383 New
11,383 $3.43 Billion

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $15B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.